Stay updated with breaking news from Comera Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
• Cash balance of $26.1 million as at March 31, 2022• Full year revenues of $2.3 million• Property and equipment value of $2.9 million• Total assets of $33 millionToronto, Ontario--(Newsfile
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 400 points on Wednesday. Following the market opening Wednesday, the...
FinancialContent fully hosted finance channel
Comera Life Sciences announced that it will collaborate with Intas Pharmaceuticals to develop a new generation of biologic medicines.
Comera will develop a differentiated formulation of an Intas product using Comera's innovative proprietary SQore formulation platform